Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641172-25-021022
Filing Date
2025-07-25
Accepted
2025-07-25 16:32:15
Documents
17
Effectiveness Date
2025-07-25

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 78920
2 EX-5.1 ex5-1.htm EX-5.1 9033
3 EX-23.1 ex23-1.htm EX-23.1 5719
4 CALCULATION OF FILING FEE TABLE ex107.htm   iXBRL EX-FILING FEES 30481
5 GRAPHIC ex5-1_001.jpg GRAPHIC 6983
6 GRAPHIC ex5-1_002.jpg GRAPHIC 10857
7 GRAPHIC ex23-1_001.jpg GRAPHIC 6779
  Complete submission text file 0001641172-25-021022.txt   286302

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 8516
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288964 | Film No.: 251152066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)